No four consecutive quarters could be summed for EPS (Diluted); these figures use the latest fiscal year, not a trailing twelve months.
Some figures named '(TTM)' on this payload are the latest FISCAL YEAR, not a trailing twelve months — eps_ttm (fiscal year ended 2025-06-30). No four consecutive quarters could be summed for them — for an IFRS 20-F filer that is every income-statement line (no quarterly income statement is tagged to EDGAR at all); for a US filer it is usually one line the quarterly tagging skips. Each field's own basis is on field_basis.
full derived coverage requires a plan
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
— Months · distinct values (the real sample size).
Metric
Today
Own median
Own range
%ile
z
Sector med.
mo · distinct
30.52×
19.76×
82nd
−0.21σ
24.86×
132 · 130
17.8%
25.5%
32nd
−0.50σ
−36.9%
132 · 11
23.7%
50.6%
32nd
−0.40σ
−15.4%
132 · 11
3.7%
6.5%
28th
−0.56σ
−21.3%
141 · 12
17.1%
4.2%
62nd
+0.14σ
5.1%
139 · 138
−0.6%
−3.6%
81st
+0.62σ
8.4%
97 · 8
11.2%
3.4%
94th
+2.10σ
9.0%
109 · 9
Market Cap
$1.48B
not reconstructed — market cap was removed from the historical pass (never a ranking factor, and a reconstructed share count carries look-ahead risk). The single stored value is the forward-captured snapshot, not a series.
Own median 19.76× × $1.19 = $23.51vs the $36.32 close · earnings held constant
Own multiple
P/E
Implied price
vs close
10th percentile
12.67×
$15.07
−58.5%
25th percentile
14.55×
$17.32
−52.3%
median
19.76×
$23.51
−35.3%
75th percentile
26.65×
$31.71
−12.7%
90th percentile
45.76×
$54.45
+49.9%
today
30.52×
$36.32
—
Reference computation · 132 monthly P/E observations in Full · EPS basis FY2025 EPS (Diluted) $1.19 · close $36.32 (2026-08-21)ⓘ
Not a forecast: each row re-prices today's filed earnings at a multiple this company itself once traded at. It abstains rather than guess on a loss year or a broken per-share basis.
Every month uses only what was filed by then, split-adjusted. Delisted names are absent and a trough year can throw one huge reading, so read the median, not the edges.
Percentile through time (point-in-time cohort)
Loading the monthly cohort placement…
▸Comp setname your own peers — pick a pool or add tickers
Covered pool$937.70B +7.6%/yr 2020→2025Concentration456 of 10,000fragmented · top 3 hold 23.1% · −151 pts since 2019PAHC0.1% · rank 47 of 385 · +0.0pp over 5y· CV 0.09 · σ 0.0pp
Who holds the poolCY2025 · bars scaled to the largest member
PAHC is not drawn here: its newest pool year (CY2024) differs from the industry’s (CY2025), so its 0.1% is a different year’s share.
Growth, restated as sharewhere each pace has to END UP, by 2029
Its own realised pace0.1% → 0.2%
The pace the price requires— The growth today's price requires (our reverse-DCF) is a Pro metric — the realized-pace runway above is free.
PAHC share over timelast 6 of 9 published years
Calendar year
2019
2020
2021
2022
2023
2024
Share of covered pool
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
year: this company's newest published… · coverage: 346 of the 377 members that…
Share of covered industry revenue · n=385 in Pharmaceuticals & Biotechnology · CY2024 pool · built 2026-08-22 not market shareⓘ
Covered filers only, not market share — private and uncovered companies are missing, so every share here reads high. Years are FX-converted and published only once most of the pool has filed.
